Sanofi-Aventis (NYSE:SNY) traded at a new 52-week high today of $48.10. This new high was reached on below average trading volume as 475,000 shares traded hands, while the average 30-day volume is approximately 1.2 million shares.
In the past 52 weeks, shares of Sanofi-Aventis have traded between a low of $33.03 and a high of $48.10 and are now at $47.75, which is 45% above that low price. Over the past week, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 0.6%.
Potential upside of 10.7% exists for Sanofi-Aventis, based on a current level of $47.75 and analysts' average consensus price target of $52.87. The stock should discover initial support at its 50-day moving average (MA) of $45.07 and subsequent support at its 200-day MA of $40.40.
Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.